CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents

Author： Douma T. Millan M. Boulay D. Griebel G. Verdouw P. Westphal K. Olivier B. Groenink L.

ISSN： 0033-3158

Source： Psychopharmacology, Vol.231, Iss.7, 2014-04, pp. : 1289-1303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

In vitro pharmacological profile of nonpeptide CRF 1 receptor antagonists, CRA1000 and CRA1001

By Chaki S. Okuyama S. Nakazato A. Kumagai T. Okubo T. Ikeda Y. Oshida Y. Hamajima Y. Tomisawa K.

European Journal of Pharmacology, Vol. 371, Iss. 2, 1999-04 ,pp. : 205-211

Elsevier

Access to resources Recommend Favorite

Effects of 1 receptor ligand, MS-377 on apomorphine- or phencyclidine-induced disruption of prepulse inhibition of acoustic startle in rats

By Yamada S. Yamauchi K. Hisatomi S. Annoh N. Tanaka M.

European Journal of Pharmacology, Vol. 402, Iss. 3, 2000-08 ,pp. : 251-254

Elsevier

Access to resources Recommend Favorite

Atypical Antipsychotics Do Not Reverse Prepulse Inhibition Deficits in Acutely Psychotic Schizophrenia

By Xue Y-Y Wang H-N Xue F Tan Q-R

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1467-1475

Field House Publishing

Access to resources Recommend Favorite

Development of CRF1 Receptor Antagonists as Antidepressants and Anxiolytics: Progress to Date

By Valdez Glenn R.

CNS Drugs, Vol. 20, Iss. 11, 2006-01 ,pp. : 887-896

Adis International

Access to resources Recommend Favorite

Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice

By Furuya Y. Kagaya T. Ogura H. Nishizawa Y.

European Journal of Pharmacology, Vol. 364, Iss. 2, 1999-01 ,pp. : 133-140

Elsevier

Access to resources Recommend Favorite